Yamamoto Akira, Iwata Akira, Saito Toshiki, Watanabe Fumiko, Ueda Susumu
Nippon Institute for Biological Science, Shin-Machi 9-2221-1, Ome, Tokyo 198-0024, Japan.
Vet Immunol Immunopathol. 2009 Aug 15;130(3-4):221-5. doi: 10.1016/j.vetimm.2009.02.016. Epub 2009 Mar 5.
Canine granulocyte colony-stimulating factor (cG-CSF) with modification of cysteine at position 17 to serine was expressed in Brevibacillus choshinensis HPD31. cG-CSF secreted into the culture medium was purified by ammonium sulfate precipitation and consecutive column chromatography, using butyl sepharose and DEAE sepharose. Biological activity of the recombinant cG-CSF was 8.0 x 10(6) U/mg protein, as determined by its stimulatory effect on NFS-60 cell proliferation. Purified cG-CSF was subcutaneously administered once a day for two successive days to dogs (1, 5, 25, or 125 microg). Neutrophil count increased the following day in all dogs except those administered the lowest dose (1 microg). No severe side effects were observed in dogs after administration of cG-CSF.
将17位半胱氨酸修饰为丝氨酸的犬粒细胞集落刺激因子(cG-CSF)在短芽孢杆菌HPD31中表达。分泌到培养基中的cG-CSF通过硫酸铵沉淀以及使用丁基琼脂糖和二乙氨基乙基琼脂糖的连续柱色谱法进行纯化。重组cG-CSF的生物活性为8.0×10⁶ U/mg蛋白质,这是通过其对NFS-60细胞增殖的刺激作用测定的。将纯化的cG-CSF以1、5、25或125微克的剂量连续两天每天皮下注射给犬。除了给予最低剂量(1微克)的犬之外,所有犬的中性粒细胞计数在第二天均增加。给予cG-CSF后,犬未观察到严重的副作用。